STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer

STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer

Background Poly (ADP-ribose) polymerase (PARP) inhibition (PARPi) has demonstrated potent therapeutic efficacy in patients with BRCA-mutant ovarian cancer. However, acquired resistance to PARPi remains a major challenge in the clinic.Methods PARPi-resistant ovarian cancer mouse models were generated...

Full description

Bibliographic Details
Main Authors:	Changli Qian, Gordon J Freeman, Tao Jiang, Ursula Matulonis, Ziying Lin, Hye-Jung Kim, Anniina Färkkilä, Hua Yu, Xin Cheng, Antons Martincuks, Joyce F Liu, Qiwei Wang, Liya Ding, Michael J Kearns, Shaozhen Xie, Inga-Maria Launonen, Thomas M Roberts, Jean J Zhao
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-01-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/11/1/e005627.full

Similar Items

STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer
by: Qiwei Wang, et al.
Published: (2022-05-01)

Targeting tumor-associated macrophages with STING agonism improves the antitumor efficacy of osimertinib in a mouse model of EGFR-mutant lung cancer
by: Ziying Lin, et al.
Published: (2023-02-01)

STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer
by: Constantia Pantelidou, et al.
Published: (2022-09-01)

PARP Inhibitor Resistance Mechanisms and Implications for Post-Progression Combination Therapies
by: Elizabeth K. Lee, et al.
Published: (2020-07-01)

Molecular mechanism of agonism and inverse agonism in ghrelin receptor
by: Jiao Qin, et al.
Published: (2022-01-01)

Woman with agonal breathing
by: Chien‐Te Hsu, et al.
Published: (2023-06-01)

Structural aspects of agonism and antagonism in the oestrogen receptor.
by: Pike, A, et al.
Published: (2000)

Intensidad dramática en "Agone"
by: María Teresa Olivera Santos
Published: (2000-12-01)

COMPETITIVENESS AND AGONALITY IN MODERN SPORTS
by: Irina L. Levina, et al.
Published: (2022-12-01)

Molecular basis of agonism and antagonism in the oestrogen receptor.
by: Brzozowski, A, et al.
Published: (1997)

Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer
by: Qingyun Zhu, et al.
Published: (2024-01-01)

Muzycznoliteracki agon tożsamości: „Konrad Wallenrod”
by: Jan Wawrzyniec Czarnecki
Published: (2020-04-01)

Politicizing Skepticism – Agonal Thought for Democracy
by: Daniel Nunes Pereira, et al.
Published: (2016-12-01)

Structural insights into the mechanisms of agonism and antagonism in oestrogen receptor isoforms.
by: Hubbard, R, et al.
Published: (2000)

Exploring Biased Agonism at FPR1 as a Means to Encode Danger Sensing
by: Jieny Gröper, et al.
Published: (2020-04-01)

Use of First-Line PARP Inhibitors in Ovarian Cancer
by: Ursula Hasler-Strub
Published: (2020-11-01)

Use of First-Line PARP Inhibitors in Ovarian Cancer
by: Ursula Hasler-Strub
Published: (2020-11-01)

Astragaloside IV Regulates cGAS-STING Signaling Pathway to Alleviate Immunosuppression Caused by PRRSV Infection
by: Ke Song, et al.
Published: (2023-07-01)

LXR agonism for CNS diseases: promises and challenges
by: Ruiyi Zhang, et al.
Published: (2024-04-01)

Agon—Are Military Officers Educated for Modern Society?
by: Leif Inge Magnussen, et al.
Published: (2023-05-01)

Agonism, decision, power – The art of working unfinished
by: John Pløger
Published: (2023-08-01)

The birth of sports from the spirit of agonal eccentricity
by: Koprivica Časlav D.
Published: (2019-01-01)

DOES CONTEMPORARY DEMOCRACY DEMANDS AGONISM OR DELIBERATION?
by: Nicolás Emanuel Olivares
Published: (2015-06-01)

The Lack of STING Impairs the MHC-I Dependent Antigen Presentation and JAK/STAT Signaling in Murine Macrophages
by: Carmen Caiazza, et al.
Published: (2022-11-01)

Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer
by: Lorna Rodriguez-Rodriguez, et al.
Published: (2024-04-01)

GIP receptor agonism blocks chemotherapy-induced nausea and vomiting
by: Tito Borner, et al.
Published: (2023-07-01)

Grouper cGAS is a negative regulator of STING-mediated interferon response
by: Luhao Zhang, et al.
Published: (2023-02-01)

Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
by: José Yélamos, et al.
Published: (2020-02-01)

MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer
by: Matias A. Bustos, et al.
Published: (2023-11-01)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
by: Lotte van Beek, et al.
Published: (2021-05-01)

Entering the Agon: dissent and authority in Homer, historiography, and tragedy
by: Barker, E
Published: (2009)

Agon: poetry’s resistance to the mathematisation of reality (1920s-1960s)
by: Sridhar, A
Published: (2020)

Hélia Correia, “Desmesura”: Un agôn au féminin
by: Maria de Fátima Silva
Published: (2009-02-01)

Prismatic agon, prismatic harmony: translation, literature, language
by: Reynolds, M
Published: (2019)

O TRÁGICO E O AGÓN EM NIETZSCHE
by: Thiago Mota Fontenele e Silva
Published: (2021-07-01)

A Systematic Review of Inverse Agonism at Adrenoceptor Subtypes
by: Martin C. Michel, et al.
Published: (2020-08-01)

Atractylodin Ameliorates Colitis via PPARα Agonism
by: Gwangbeom Heo, et al.
Published: (2023-01-01)

AGON AS AN IMMANENT CHARACTERISTIC FEATURE OF ANCIENT GREEK CULTURE
by: Evgeny Y. Rezhabek, et al.
Published: (2011-07-01)

Luis Cernuda y agón o lucha literaria
by: Jae Won Chang
Published: (2017-11-01)

T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer
by: Lin Li, et al.
Published: (2022-09-01)